ASCENTAGE PHARMA GROUP(AAPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AAPG ASCENTAGE PHARMA GROUP

Post-Mkt 10-22 18:53:47 EDT

14.92

-1.42

-8.69%

盘后14.92

+0.000.00%

16:25 EDT

High15.30	Low14.90	Vol18.78K
Open15.30	D1 Closing16.34	Amplitude2.45%
Mkt Cap1.39B	Tradable Cap1.07B	Total Shares93.33M
T/O284.20K	T/O Rate0.03%	Tradable Shares71.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"ASCENTAGE PHARMA GROUP","latestPrice":14.92,"timestamp":1792699200000,"preClose":16.34,"halted":0,"volume":18779,"hourTrading":{"tag":"盘后","latestPrice":14.92,"preClose":14.92,"latestTime":"16:25 EDT","volume":122,"amount":1820.24,"timestamp":1792700704078,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08690330477356181,"floatShares":71582800,"shares":93330405,"eps":-2.325979,"marketStatus":"Post-Mkt","change":-1.42,"latestTime":"10-22 18:53:47 EDT","open":15.3,"high":15.3,"low":14.9,"amount":284201,"amplitude":0.02448,"askPrice":16.6,"askSize":100,"bidPrice":14.6,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-2.325979,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792713600000},"marketStatusCode":4,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":16.34,"preHourTrading":{"tag":"盘前","latestPrice":15.27,"preClose":16.34,"latestTime":"09:29 EDT","volume":5464,"amount":83456.157944,"timestamp":1792675799058,"change":-1.07,"changeRate":-0.065483,"amplitude":0.0306},"postHourTrading":{"tag":"盘后","latestPrice":14.92,"preClose":14.92,"latestTime":"16:25 EDT","volume":122,"amount":1820.24,"timestamp":1792700704078,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.74154},"requestUrl":"/m/hq/s/AAPG/wiki","defaultTab":"wiki","newsList":[{"id":"1111302288","title":"Ascentage Pharma Trustee Acquires 200,000 Shares for 2022 Restricted Share Unit Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1111302288","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111302288?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:52","pubTimestamp":1792673532,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (06855) announced that on October 22, 2026, the trustee purchased a total of 200,000 existing shares on the market for the purpose of the 2022 Restricted Share Unit Plan, in order to satisfy restricted share units upon vesting.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK1574","BK1161","06855","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677622226","title":"Ascentage Pharma's Lisaftoclax Granted China Breakthrough Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2677622226","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677622226?lang=en_us&edition=fundamental","pubTime":"2026-10-21 17:49","pubTimestamp":1792576143,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International  said Tuesday that China's Center for Drug Evaluation has granted breakthrough therapy designation to lisaftoclax in combination with acalabrutinib for treatment-naive adults with chronic lymphocytic leukemia/small lymphocytic lymphoma .Candidates granted the designation in China receive priority for official communications and development guidance to speed up drug development, the company said.Eligible candidates may also apply for priority review and conditional approval when submitting a new drug application in China, it added.Ascentage Pharma is currently conducting four global registrational phase 3 trials of lisaftoclax, the company said.The drug remains investigational in the US, and the lisaftoclax-acalabrutinib combination has not been approved in any market, Ascentage Pharma said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102612614","title":"Ascentage Pharma Shares Rise Over 4% in Early Trading as Lisaftoclax Receives Breakthrough Therapy Designation from Drug Review Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1102612614","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102612614?lang=en_us&edition=fundamental","pubTime":"2026-10-21 10:40","pubTimestamp":1792550415,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (06855) shares rose more than 4% in early trading. As of press time, the stock was up 4.25% at HK$31.86, with a turnover of HK$28.9748 million.On the news front, Ascentage Pharma...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","06855","BK1161","BK4139","VXUS","BK1574","BK4585","KCAI","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675551886","title":"Ascentage Pharma initiated with an Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2675551886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675551886?lang=en_us&edition=fundamental","pubTime":"2026-10-16 08:35","pubTimestamp":1792110927,"startTime":"0","endTime":"0","summary":"William Blair analyst Alethia Young initiated coverage of Ascentage Pharma (AAPG) with an Outperform rating. Ascentage remains under the radar to m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675435693","title":"Ascentage Pharma Group International : Citigroup Initiates Coverage with Buy Rating; Target Price $46","url":"https://stock-news.laohu8.com/highlight/detail?id=2675435693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675435693?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:24","pubTimestamp":1791973481,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nFWN460113:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AAPG","BK1574","BK1161","06855","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172839647","title":"Ascentage Pharma: A Dancer on the High Wire","url":"https://stock-news.laohu8.com/highlight/detail?id=1172839647","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172839647?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:21","pubTimestamp":1791526895,"startTime":"0","endTime":"0","summary":"Based on publicly available information. This is for informational exchange only and does not constitute any investment advice.Innovative drug development is a business of trading time for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","AAPG","BK1161","BK4139","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673604744","title":"Ascentage Pharma Group International : JP Morgan Cuts Target Price to $33 from $46","url":"https://stock-news.laohu8.com/highlight/detail?id=2673604744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673604744?lang=en_us&edition=fundamental","pubTime":"2026-10-08 11:44","pubTimestamp":1791431085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45T1ZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06855","BK4139","BK1161","AAPG","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129729611","title":"Ascentage Pharma Trustee Acquires 50,000 Shares for 2022 Restricted Share Unit Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1129729611","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129729611?lang=en_us&edition=fundamental","pubTime":"2026-09-17 21:04","pubTimestamp":1789650279,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International (06855) has announced that on September 17, 2026, its appointed trustee purchased a total of 50,000 existing shares on the market to fulfill obligations under the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK4139","BK1161","BK1574","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812806","title":"Analysts Offer Insights on NA Companies: PACS Group Inc (PACS) and Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812806?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:10","pubTimestamp":1788354640,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on PACS Group Inc (PACS) and Ascentage Pharma Group Internation...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-pacs-group-inc-pacs-and-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-pacs-group-inc-pacs-and-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAPG","NA","DIVL","APIE","SAPH","BK4185","CVY","ARMH","PACS","AADR","BK4139","DINT","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811892","title":"Ascentage Pharma to Participate in Four Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811892","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811892?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355066/0/en/ascentage-pharma-to-participate-in-four-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260487","title":"Oppenheimer Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260487","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260487?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:55","pubTimestamp":1787313347,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Jeff Jones maintained a Buy rating on Ascentage Pharma Group International Unsponsored ADR today and set a price target of $45....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","SAPH","ARMH","DIVL","DINT","AADR","APIE","CVY","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660401977","title":"Ascentage Pharma H1 Loss Widens, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2660401977","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660401977?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:28","pubTimestamp":1787210936,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group  reported an H1 loss Wednesday of 2.19 Chinese renminbi  per diluted share, widening from a loss of 1.73 renminbi a year earlier.Revenue for the half-year ended June 30 was 302.2 million renminbi, up from 233.7 million renminbi a year earlier.Shares of the company were down more than 2% in Thursday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["YINN","02822","ASHR","AAPG","02823","YANG","YXI","XPP","ASHS","KGRN","CWEB","CHAU","KCAI","82822","82843","FXP","82823","FLCH","BK4139","02843","KWEB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660529406","title":"Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660529406","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660529406?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:18","pubTimestamp":1787206735,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group (NASDAQ:AAPG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.44) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.24) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61320938/reported-earlier-ascentage-pharma-group-h1-eps-0-32-beats-0-44-estimate-sales-44-541m-beat-24-070m-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199487193","title":"Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1199487193","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199487193?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:40","pubTimestamp":1787182818,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced its interim results for the first half of 2026, showcasing continued momentum in its commercial operations. Total revenue for the period...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06855","AAPG","BK4139","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660471837","title":"Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660471837","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660471837?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180400,"startTime":"0","endTime":"0","summary":"Revenue for the first half of 2026 increased29% year-over-year to US$44.5 million (RMB302.2 million), primarily attributable to increased product sales. Expanded executive leadership with appointments","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3348052/0/en/ascentage-pharma-reports-2026-interim-unaudited-financial-results-and-provides-business-updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4139","DTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659615457","title":"Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2659615457","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659615457?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622400,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Aug.  13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biophar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344461/0/en/ascentage-pharma-to-participate-in-the-evercore-2nd-annual-china-biotech-summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG","BK4588","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158593007","title":"Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1158593007","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158593007?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:51","pubTimestamp":1786506676,"startTime":"0","endTime":"0","summary":"Abstract ASCENTAGE PHARMA GROUP is scheduled to release quarterly results on August 19, 2026 Pre-Mkt, and consensus points to faster top-line growth with narrowing per-share losses as its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547113","title":"CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547113","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547113?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:07","pubTimestamp":1785935220,"startTime":"0","endTime":"0","summary":"In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),please note that in the first paragraph of the release, the time should be ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/05/3339389/0/en/CORRECTION-Ascentage-Pharma-to-Report-2026-Six-Month-Interim-Results-and-Provide-Corporate-Update-on-August-19-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656102346","title":"Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2656102346","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656102346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:00","pubTimestamp":1785715214,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (AAPG) Group announced the appointment of Faical Miyara, PhD, as Chief Business Officer, CBO, responsible for the Company’s global...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-appoints-miyara-as-cbo-ziegler-as-cco-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-appoints-miyara-as-cbo-ziegler-as-cco-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2294711713.HKD","LU2506951792.HKD","BK4139","LU0823414478.USD","LU2249611893.SGD","LU0823414551.USD","BK4009","CCO","LU2357125470.USD","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177768322","title":"ASCENTAGE PHARMA GROUP Appoints Two Key Executives to Lead Global Business and Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1177768322","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177768322?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:40","pubTimestamp":1785714027,"startTime":"0","endTime":"0","summary":"ASCENTAGE PHARMA GROUP (06855) announced the appointment of Dr. Faiçal Miyara as Chief Business Officer (CBO) and Jim Ziegler as Chief Commercial Officer (CCO), effective immediately.Dr. Miyara will...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06855","BK1574","BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentage.com","stockEarnings":[{"period":"1week","weight":0.1003},{"period":"1month","weight":0.0303},{"period":"3month","weight":-0.1545},{"period":"6month","weight":-0.3177},{"period":"1year","weight":-0.5258},{"period":"ytd","weight":-0.3773}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ascentage Pharma Group is a holding company primarily engaged in the discovery, development, and commercialization of therapeutics for hematologic malignancies. Its core business focuses on developing and selling novel small-molecule therapies targeting cancer, hepatitis B, and age-related diseases. Key products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), and APG-5918, which are mainly used to treat hematologic malignancies such as chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, and multiple myeloma. The company primarily operates in the domestic Chinese market.","exchange":"NASDAQ","name":"ASCENTAGE PHARMA GROUP","nameEN":"ASCENTAGE PHARMA GROUP","securityTypeName":"DR","adrRate":"1:4"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ASCENTAGE PHARMA GROUP(AAPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ASCENTAGE PHARMA GROUP(AAPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ASCENTAGE PHARMA GROUP,AAPG,ASCENTAGE PHARMA GROUP股票,ASCENTAGE PHARMA GROUP股票老虎,ASCENTAGE PHARMA GROUP股票老虎国际,ASCENTAGE PHARMA GROUP行情,ASCENTAGE PHARMA GROUP股票行情,ASCENTAGE PHARMA GROUP股价,ASCENTAGE PHARMA GROUP股市,ASCENTAGE PHARMA GROUP股票价格,ASCENTAGE PHARMA GROUP股票交易,ASCENTAGE PHARMA GROUP股票购买,ASCENTAGE PHARMA GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ASCENTAGE PHARMA GROUP(AAPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ASCENTAGE PHARMA GROUP(AAPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction